For the quarter ending 2025-09-30, MNTS had $538K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -11,074 | -12,622 |
| Depreciation and amortization | 323 | 647 |
| Amortization of debt (premium) and issuance costs | 74 | -381 |
| Amortization of right-of-use asset | 26 | 39 |
| Change in fair value of convertible debt carried at fair value | 0 | -835 |
| Loss on disposal of fixed and intangible assets | 0 | 0 |
| Loss on debt extinguishment | -2,898 | 71 |
| Loss on issuance of warrant liabilities | -1,391 | - |
| Stock-based compensation expense | 691 | 2,024 |
| Issuance of convertible notes for legal services | 39 | 384 |
| Accounts receivable | -200 | -679 |
| Prepaids and other current assets | 2,452 | 2,165 |
| Insurance receivable | 0 | -308 |
| Other non-current assets | -2,167 | -495 |
| Accounts payable | -78 | 1,480 |
| Accrued liabilities | 301 | 379 |
| Accrued interest | 209 | 270 |
| Other current liabilities | 18 | 502 |
| Contract liabilities | -1 | 900 |
| Operating lease liability | -159 | -302 |
| Litigation settlement contingency | 0 | -308 |
| Other non-current liabilities | 104 | -515 |
| Net cash used in operating activities | -5,323 | -7,422 |
| Proceeds from sale of property, machinery and equipment | 0 | - |
| Purchases of intangible assets | 0 | 0 |
| Net cash provided by investing activities | 0 | 0 |
| Proceeds from issuance of convertible notes and warrants | 2,072 | 178 |
| Payment of convertible notes | 1,390 | 672 |
| Principal payments on loan payable | 0 | 0 |
| Payment of debt issuance costs | 167 | 78 |
| Proceeds from exercise of warrants | 2,698 | 2,068 |
| Payments for issuance costs related to exercise of warrants | 293 | 204 |
| Proceeds from issuance of loan payable | - | 0 |
| Repurchase of section 16 officer shares for tax coverage exchange | 0 | 1 |
| Proceeds from issuance of warrants | - | 572 |
| Payment of deferred offering costs | -138 | 283 |
| Proceeds from issuance of common stock and related warrants | 4,000 | 5,000 |
| Payments for issuance costs related to common stock and related warrants | 625 | 598 |
| Net cash provided by financing activities | 5,861 | 5,982 |
| Decrease in cash and cash equivalents | 538 | -1,440 |
| Cash and cash equivalents at beginning of period | 1,572 | - |
| Cash and cash equivalents at end of period | 670 | - |
Momentus Inc. (MNTS)
Momentus Inc. (MNTS)